These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 14765034)

  • 21. The role of noninvasive imaging in coronary artery disease detection, prognosis, and clinical decision making.
    Dowsley T; Al-Mallah M; Ananthasubramaniam K; Dwivedi G; McArdle B; Chow BJ
    Can J Cardiol; 2013 Mar; 29(3):285-96. PubMed ID: 23357601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of exercise echocardiography with myocardial perfusion scintigraphy for the diagnosis of coronary artery disease.
    Salustri A; Pozzoli MM; Reijs AE; Fioretti PM; Roelandt JR
    Herz; 1991 Oct; 16(5):388-94. PubMed ID: 1757065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of digital dobutamine stress echocardiography in the noninvasive evaluation of coronary artery disease.
    Madu EC; Ahmar W; Arthur J; Fraker TD
    Arch Intern Med; 1994 May; 154(10):1065-72. PubMed ID: 8185419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of perfusion myocardial scintigraphy with gated SPECT technique in the diagnostic and prognostic evaluation of patients with chronic coronary disease].
    Leoncini M; Sciagrà R
    Ital Heart J Suppl; 2002 Mar; 3(3):309-18. PubMed ID: 12040846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating coronary artery disease noninvasively--which test for whom?
    Chou TM; Amidon TM
    West J Med; 1994 Aug; 161(2):173-80. PubMed ID: 7941543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise thallium-201 single photon emission computed tomography for the diagnosis of coronary artery disease: what should we expect from SPECT?
    Williams KA; Lipton MJ
    J Am Coll Cardiol; 1990 Feb; 15(2):330-3. PubMed ID: 2299072
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessing mature technology: what is the effect of high-quality risk stratification evidence with exercise echocardiography and single-photon emission computed tomography imaging?
    Shaw LJ; Polk D; Merz CN
    J Am Coll Cardiol; 2007 Jan; 49(2):238-9. PubMed ID: 17222735
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of stress echocardiography for assessment of coronary artery disease: what we know and what we need to know.
    Marwick TH
    Eur J Echocardiogr; 2000 Mar; 1(1):22-31. PubMed ID: 11916582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease.
    Beller GA; Zaret BL
    Circulation; 2000 Mar; 101(12):1465-78. PubMed ID: 10736294
    [No Abstract]   [Full Text] [Related]  

  • 30. Stress imaging. Current clinical options for the diagnosis, localization, and evaluation of coronary artery disease.
    Botvinick EH
    Med Clin North Am; 1995 Sep; 79(5):1025-61. PubMed ID: 7674684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET replaces thallium for some cardiologists.
    Zoler ML
    Diagn Imaging (San Franc); 1990 Aug; 12(8):146-7. PubMed ID: 10183701
    [No Abstract]   [Full Text] [Related]  

  • 32. Prior restraint: a Bayesian perspective on the optimization of technology utilization for diagnosis of coronary artery disease.
    Diamond GA; Denton TA; Berman DS; Cohen I
    Am J Cardiol; 1995 Jul; 76(1):82-6. PubMed ID: 7793413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance.
    Fleischmann KE; Hunink MG; Kuntz KM; Douglas PS
    J Nucl Cardiol; 2002; 9(1):133-4. PubMed ID: 11883393
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic indicators for coronary artery disease: ready for the bedside?
    Goldstein RE; Holmboe ES
    JAMA; 1999 Feb; 281(6):565-6. PubMed ID: 10022116
    [No Abstract]   [Full Text] [Related]  

  • 35. A consideration of current clinical options for stress imaging in the diagnosis and evaluation of coronary artery disease.
    Botvinick EH
    J Nucl Cardiol; 1994; 1(5 Pt 2):S147-70. PubMed ID: 9420740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stress imaging in coronary artery disease: state of the art].
    Baldini U; Venturini C; Genovesi-Ebert A; Savoia MT; Raugi M; Pauletti M; Carluccio M; Digiorgio A; Gasperetti G; Galli M
    Minerva Cardioangiol; 2004 Feb; 52(1):19-27. PubMed ID: 14765034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of stress echocardiography and competing technologies for the diagnostic and prognostic assessment of coronary artery disease.
    Mastouri R; Mahenthiran J; Sawada SG
    Minerva Cardioangiol; 2009 Aug; 57(4):367-87. PubMed ID: 19763064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of stress dobutamine technetium-99m sestamibi single-photon emission computed tomography (SPECT) in patients with suspected coronary artery disease.
    Senior R; Raval U; Lahiri A
    Am J Cardiol; 1996 Nov; 78(10):1092-6. PubMed ID: 8914869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radionuclide perfusion imaging techniques for evaluation of patients with known or suspected coronary artery disease.
    Beller GA
    Adv Intern Med; 1997; 42():139-201. PubMed ID: 9048119
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological (stress) perfusion scintigraphy: methods, advantages, and applications.
    Bateman TM; O'Keefe JH
    Am J Card Imaging; 1992 Mar; 6(1):3-13; discussion 14-5. PubMed ID: 10147612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.